The producer price index fell 0.3% in June, defying forecasts that had expected the wholesale inflation measure to remain unchanged for the month. The Bureau of Labor Statistics released the figures on
More
London’s most prestigious law firms are facing significant financial and strategic obstacles as they attempt to establish themselves in the highly competitive New York legal market. Breaking into the US has been
More
Sanofi has filed two separate federal lawsuits against Moderna and Pfizer, alleging that several major Covid-19 and RSV vaccines infringe its mRNA delivery patents. The French pharmaceutical giant, listed on US markets
More
Cryoport Systems is repositioning the conversation around supply chains for advanced therapies, arguing that quality must be embedded from the ground up rather than applied as an afterthought. Adam Fox, Chief Quality
More
South Carolina’s Supreme Court has issued a significant ruling that protects the ability of individuals and companies serving in key fiduciary roles across the state. The July 15, 2026 decision in South
More
The law firms that struck agreements with the Trump administration are finding those arrangements have generated far more problems than they solved. Reports suggest the deals negotiated between several prominent Biglaw firms
More
The FTSE 100 closed lower on Wednesday as a disappointing Chinese growth reading sent mining stocks sharply lower across London’s lead index. The index finished down 13.47 points, or 0.1%, at 10,515.92,
More
The FIFA World Cup delivered a welcome lift to bars and restaurants in host cities, though the wider economic impact fell short of expectations, the Federal Reserve has found. The Federal Reserve’s
More
The British Retail Consortium has laid out a series of demands for Andy Burnham as he prepares to enter government as Prime Minister. The BRC, which represents the UK’s biggest retailers, has
More
Merck (MRK) has announced that its flagship cancer drug Keytruda has achieved a landmark result in the treatment of a specific endometrial cancer subtype. The drug became the first PD-1 inhibitor to
More